敏感化瘤免疫疗法:免疫性细胞死亡诱导纳米系统
Jianlan Peng1, Shiying Li2, Huihui Ti1,3
1School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
International journal of nanomedicine
|June 19, 2024
概括
瘤免疫疗法由于瘤免疫性较低而面临挑战. 纳米材料可以诱导免疫细胞死亡 (ICD),增强抗瘤免疫力,并可能改善癌症治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 材料科学 材料科学 材料科学
背景情况:
- 低瘤免疫性阻碍了有效的癌症免疫疗法.
- 化疗,放射治疗和光疗等治疗策略可以诱导免疫细胞死亡 (ICD).
- ICD释放瘤抗原并成熟树突细胞 (DC),促进抗瘤免疫反应.
研究的目的:
- 审查ICD的机制和诱导方法.
- 探索ICD和瘤免疫之间的关系.
- 检查使用纳米材料诱导ICD用于增强癌症免疫治疗的进展.
主要方法:
- 对ICD诱导剂和癌症免疫疗法的现有文献的综述.
- 分析ICD增强抗瘤免疫力的机制.
- 研究纳米系统在调节ICD和免疫反应中的作用.
主要成果:
- 单个ICD诱导剂往往无法实现完全的瘤切除或长期免疫.
- 纳米系统为增强ICD诱导和瘤免疫疗法提供了一个有前途的方法.
- 纳米材料的特性影响ICD水平和潜在的有毒副作用.
结论:
- 基于纳米材料的ICD诱导剂具有改善癌症免疫治疗的巨大潜力.
- 需要进一步的研究来优化纳米材料设计,以提高ICD和降低毒性.
- 本综述为开发基于纳米材料的ICD诱导剂的临床应用提供了理论指导.
相关概念视频
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Cytotoxic T Cells-mediated Immune Response
889
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
889


